Table 3.
Cytokine And Tight Junction Proteins Of Different Groups
| CNSL group(n=4) | Non-CNSL(n=4) | AML-CNSL(n=3) | AML-non-CNSL(n=4) | |
|---|---|---|---|---|
| MMP-9CSF (ng/mL) | 15.24(0.49–36.46) | 0.36(0.36–0.37)* | 0.41(0.39–0.50) | 0.37(0.37–0.38)** |
| MMP-9Serum (ng/mL) | 82.44(24.27–184.99) | 125.22(68.71–169.40) | 79.75(18.60–538.28) | 127.00(73.46–793.78)** |
| CCL2CSF (pg/mL) | 1922.04(1039.41–2553.66) | 490.68(245.51–658.80) | 747.53(286.37–1181.84)** | 517.54(459.16–526.88)** |
| CCL2Serum (pg/mL) | 328.40(247.84–698.50) | 363.43(198.81–508.20) | 495.35(229.16–895.81) | 213.99(183.63–282.87) |
| sVCAM-1CSF (ng/mL) | 61.36(9.21–118.24) | 9.00(8.09–10.63) | 12.01(9.78–21.04) | 11.77(9.75–12.15) |
| sVCAM-1Serum (ng/mL) | 1546.95(1148.11–1971.14) | 1092.34(859.12–1361.05) | 2402.09(1492.87–2898.95) | 1410.06(1090.65–1830.87) |
| CLDN5CSF (pg/mL) | 234.92(144.77–635.82) | 281.06(238.08–329.27) | 200.22(95.65–421.64) | 215.42(203.54–257.04) |
| CLDN5Serum (pg/mL) | 115.75(82.18–161.60) | 100.93(74.44–153.18) | 110.61(91.90–165.48) | 93.23(92.03–117.20) |
| OCLNCSF (pg/mL) | 6.68(2.80–10.63) | 2.59(1.09–3.96) | 0.71(0.32–0.93) | 0.39(0.20–0.70) |
| OCLNSerum (pg/mL) | 7.11(3.26–16.89) | 6.94(4.67–9.53) | 15.51(11.26–22.11) | 7.28(5.83–10.35) |
| ZO-1CSF (pg/mL) | 710.04(590.52–777.18) | 182.98(174.11–191.14)* | 208.76(143.24–394.13) | 122.24(110.16–167.32)** |
| ZO-1Serum (pg/mL) | 1549.60(1121.47–1790.29) | 939.75(680.12–1102.58) | 1925.50(1718.23–1976.06) | 1039.49(900.80–1170.52) |
Note: *p ≤0.05 and **p ≤0.01 when compared with lymphoma group.